It is estimated that over half of the global population owns a mobile phone, and with 680 million active mobile users of Facebook each month and 120 million using Twitter on their mobile phones, the opportunity to reach the patient is huge. Bill Byrom of Parexel Informatics explores the different ways in which functionality can be delivered to mobile devices, and the benefits and limitations of each when applied to the collection of eCOA in clinical trials.